LEADER 01381nam  2200385   450 
001 9910701241003321
005 20220517112802.0
035   $a(CKB)5470000002416649
035   $a(OCoLC)980875110
035   $a(EXLCZ)995470000002416649
100   $a20170403d2011      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aEconomic analysis of the causes of drug shortages
210  1$aWashington, DC :$cOffice of the Assistant Secretary for Planning and Evaluation, Office of Science and Data Policy, U.S. Department of Health and Human Services,$d2011.
215   $a1 online resource (19 pages) $ccolor illustrations
225 1 $aASPE issue brief
300   $a"October 2011."
320   $aIncludes bibliographical references.
606   $aPharmaceutical industry$zUnited States
606   $aDrug accessibility$zUnited States
606   $aDrugs$xPrices$zUnited States
615  0$aPharmaceutical industry
615  0$aDrug accessibility
615  0$aDrugs$xPrices
712 02$aUnited States.$bDepartment of Health and Human Services.$bOffice of Science and Data Policy,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701241003321
996   $aEconomic analysis of the causes of drug shortages$93200393
997   $aUNINA